2022 年度业绩说明会"的公告 本公司及全体董事会成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者遗漏。 西安蓝晓科技新材料股份有限公司（以下简称"公司"）《2022 年年度报 告》全文及其摘要已于 2023 年 4 月 26 日披露。为促进上市公司规范运作、健康 发展，增强公司信息透明度，加强与广大投资者沟通交流，进一步提升投资者关 系管理水平，陕西上市公司协会根据陕西证监局工作部署，联合深圳市全景网络 有限公司举办"2023 年陕西辖区上市公司投资者集体接待日暨 2022 年度业绩说 明会活动"。 届时，公司董事长高月静女士、财务总监安源女士、董事会秘书于洋先生、 独立董事强力先生、保荐代表人雒晓伟先生将通过互动平台与投资者进行网络沟 通和交流，欢迎广大投资者踊跃参加。 活动时间：2023 年 5 月 16 日 15:00-17:00。 | 证券代码：300487 | 证券简称：蓝晓科技 公告编号：2023-038 | | --- | --- | | 债券代码：123195 | 债券简称：蓝晓转02 | 西安蓝晓科技新材料股份有限公司 关于参加"2023 年陕西辖区上市公司投资者集 ...

Financial Performance - The company's annual revenue for 2022 reached 1.92 billion yuan, representing a year-on-year growth of 60.69%[2] - Net profit for 2022 was 540 million yuan, an increase of 72.9% compared to the previous year, marking a historical high[2] - The company's operating revenue for 2022 was approximately CNY 1.92 billion, representing a 60.69% increase compared to CNY 1.19 billion in 2021[24] - Net profit attributable to shareholders for 2022 was approximately CNY 537.51 million, a 72.91% increase from CNY 310.86 million in 2021[24] - The cash flow from operating activities for 2022 was approximately CNY 723.75 million, showing a significant increase of 106.61% compared to CNY 350.30 million in 2021[24] - Basic earnings per share for 2022 were CNY 1.63, a 13.99% increase from CNY 1.43 in 2021[24] - The company's total production of adsorption materials was 48,500 tons in 2022, a year-on-year increase of 43%, while sales volume reached 43,200 tons, up 34% year-on-year[88] - The life sciences segment achieved sales revenue of 318 million yuan in 2022, representing a year-on-year growth of 58%[86] - The company's overseas sales revenue reached 404 million yuan in 2022, an increase of 46.8% year-on-year, driven by growth in high-end drinking water, metal extraction, and biopharmaceuticals[86] Cash Flow and Assets - The net cash flow at the end of the period was 724 million yuan, a significant increase of 106.6% year-on-year, supporting new technology development[2] - The total assets of the company amounted to 4.56 billion yuan, with a net asset return rate of 22.63%, up by 6.2% year-on-year[2] - The company's total assets grew to 4.563 billion yuan, a 47% increase year-on-year, while total liabilities increased by 81.7% to 1.826 billion yuan[84] - The company's cash and cash equivalents increased by 183.29% to ¥488,220,574.89, primarily due to higher cash receipts from sales[114] - The total assets at the end of 2022 were significantly impacted by an increase in cash and accounts receivable, with cash constituting 29.49% of total assets[117] Research and Development - The company is focusing on innovation and has seen over 20% of its annual revenue contribution from technologies developed in the past 15 years[3] - Research and development expenses amounted to 121 million yuan in 2022, accounting for 6.3% of total revenue, reflecting the company's commitment to innovation[90] - The company has established a research and development team of over 200 members, covering various fields such as polymer materials, organic synthesis, and biomedical applications[74] - The company has achieved important industrial breakthroughs in electronic-grade and nuclear-grade ultra-pure water fields, addressing critical supply chain issues[44] - The company has developed a modular adsorption separation technology for lithium extraction, which is being promoted in various regions including Tibet and South America, addressing the challenges of low lithium content in Chinese salt lakes[54] Market Expansion and Strategy - The company is expanding its international business, with a significant increase in the proportion of international market business volume, while implementing effective market development plans to reduce regulatory risks[11] - The company is strategically diversifying its product applications across various industries, including metal resources and life sciences, to mitigate risks from market fluctuations[9] - The company has signed multiple industrialization orders for lithium extraction from salt lake brine, with a total capacity of 78,000 tons of lithium carbonate/hydroxide, five of which have already commenced operations[54] - The company is focusing on expanding its system integration device business, which has become a significant profit growth point due to increased collaboration with innovative clients[48] - The company plans to expand its international strategy, targeting high-end brands in existing markets and establishing a sales network in countries like Belgium, Germany, and Argentina[139] Product Development and Innovation - The company has developed adsorption separation technology applicable across multiple fields, although current revenue impact is limited as these new businesses are still in the early stages of market development[13] - The company has developed two types of resins for vitamin B12 purification, enhancing yield and impurity removal efficiency[112] - The company launched a new protein A affinity filler in the life sciences sector, which successfully passed customer trials and is being used in ongoing projects[91] - The company has achieved market commercialization of its supercoiled plasmid purification series fillers and processes, enhancing its product offerings in the biopharmaceutical sector[111] - The company is focusing on developing high-end brands with technical characteristics to seek market breakthroughs and gradually increase market share[87] Risk Management - The company is committed to improving internal controls and management efficiency to adapt to its rapid growth and complex organizational structure[6] - The company is addressing the risk of increased asset depreciation due to the rapid growth of fixed assets by enhancing market expansion efforts to ensure timely project benefits[12] - The company is enhancing accounts receivable management to mitigate risks associated with extended customer settlement periods[147] - The company is facing management risks due to rapid business expansion, which may complicate organizational structure and management systems[145] - The company is at risk of intensified market competition as more players enter the emerging application fields of adsorption separation technology[146] Shareholder and Governance - The company plans to distribute a cash dividend of 6.42 CNY per 10 shares and will increase capital reserves by 5 shares for every 10 shares held[13] - The company has established a performance evaluation and incentive mechanism linking senior management compensation to business performance[160] - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[156] - The company held three shareholder meetings in 2022, with participation rates of 55.51%, 56.08%, and 59.74% respectively[171] - The company is committed to maintaining compliance with regulations and ensuring the protection of shareholder rights[191] Employee Management - The company is focusing on talent recruitment and aims to create a positive cycle between talent and platform to boost R&D innovation[141] - The total number of employees at the end of the reporting period was 1,311, with 704 in the parent company and 607 in major subsidiaries[195] - The company actively implements a training program for employees, covering various areas such as onboarding, business skills, management enhancement, and safety training[198] - The company has a profit distribution policy that emphasizes reasonable returns to investors while ensuring sustainable development, with a minimum cash dividend ratio of 30% of the average distributable profit over three years[200] - The company has no outsourced labor, indicating a focus on internal workforce management[199]

Financial Performance - The company's revenue for Q1 2023 was ¥500,784,017.65, representing a 50.90% increase compared to ¥331,861,373.81 in the same period last year[3] - Net profit attributable to shareholders for Q1 2023 was ¥133,874,457.07, a 66.28% increase from ¥80,512,255.70 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥129,254,652.49, up 66.11% from ¥77,814,793.53 in the previous year[3] - Operating profit for the current period was ¥157,251,835.50, compared to ¥90,381,599.62 in the previous period, marking an increase of approximately 74.0%[19] - Net profit for the current period was ¥135,479,267.39, up from ¥78,700,359.47, indicating a growth of around 72.2%[19] Earnings and Shares - Basic and diluted earnings per share for Q1 2023 were both ¥0.4, an increase of 8.11% from ¥0.37 in the previous year[3] - Basic earnings per share increased to ¥0.40 from ¥0.37, representing an increase of approximately 8.1%[20] - The company reported a total of 33,292,041.00 shares in lock-up at the end of the period, down from 33,427,791.00 shares at the beginning, indicating a decrease of approximately 0.40%[11] Cash Flow and Liquidity - The company's cash flow from operating activities for Q1 2023 was ¥129,317,646.12, reflecting a 15.29% increase from ¥112,166,192.25 in the same period last year[3] - Cash flow from operating activities generated ¥501,664,216.10, compared to ¥417,648,123.30 in the previous period, an increase of about 20.1%[21] - The total cash and cash equivalents at the end of the period reached 1,327,720,347.80, up from 856,020,294.47 in the previous year[23] - The cash and cash equivalents stood at RMB 1,424,987,846.11, compared to RMB 1,345,405,175.84 at the start of the year, representing a growth of approximately 5.89%[14] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥4,716,326,079.50, a 3.37% increase from ¥4,562,618,498.44 at the end of the previous year[3] - The total liabilities of the company were RMB 1,829,351,011.25, slightly up from RMB 1,826,329,565.16, showing a marginal increase of 0.06%[16] - The company's total current assets reached RMB 3,348,261,049.32, up from RMB 3,190,402,838.79 at the beginning of the year, indicating an increase of about 4.94%[15] - The inventory as of March 31, 2023, was RMB 998,582,559.56, up from RMB 962,717,206.08 at the beginning of the year, indicating an increase of approximately 3.71%[14] Expenses - Research and development expenses for Q1 2023 were ¥29,808,280.53, a 62.27% increase from ¥18,369,672.92 in the same period last year[6] - The company reported a significant increase in sales expenses, which rose by 208.45% to ¥17,215,636.20 due to increased share-based payments[6] - Total operating costs increased to ¥343,263,033.70 from ¥242,512,900.08, reflecting a rise of about 41.6%[18] - Tax expenses for the current period were ¥21,753,128.11, compared to ¥11,577,041.75 in the previous period, indicating an increase of approximately 88.1%[19] Investment Activities - The company invested 30,000,000.00 in capital expenditures during the quarter, a significant increase compared to 5,121,818.17 in the previous year[23] - Cash flow from investing activities totaled ¥30,345,000.00, up from ¥20,337,883.56, reflecting a growth of approximately 49.5%[22] - The net cash flow from investment activities was -10,833,171.80, compared to 15,216,065.39 in the previous year, indicating a significant decrease in investment returns[23] Financing Activities - Cash inflow from financing activities totaled 62,286,334.68, an increase from 52,535,100.00 in the same period last year[23] - The net cash flow from financing activities was 44,131,111.07, slightly down from 49,231,501.04 year-over-year[23] - The company plans to issue convertible bonds to unspecified investors, as approved in the board meeting on April 12, 2023[13] Other Information - The company received government subsidies amounting to ¥4,189,521.27 during the reporting period[4] - The first quarter report was not audited, which may affect the reliability of the financial data presented[23] - The company experienced a negative impact of -5,548,411.84 from exchange rate fluctuations on cash and cash equivalents[23] - The cash outflow for debt repayment was 17,800,000.00, compared to 3,000,000.00 in the previous year, showing increased debt management efforts[23]

Financial Performance - The company reported a revenue of RMB 1.2 billion for the year 2021, representing a year-on-year increase of 25%[29]. - The gross profit margin for 2021 was 35%, compared to 30% in the previous year, indicating improved profitability[29]. - The company's operating revenue for 2021 was ¥1,194,906,530.13, representing a 29.51% increase compared to ¥922,630,930.07 in 2020[34]. - The net profit attributable to shareholders for 2021 was ¥310,856,595.18, a 53.85% increase from ¥202,054,919.34 in 2020[34]. - The net cash flow from operating activities reached ¥350,304,974.18, a 34.51% increase from ¥260,427,752.05 in 2020[34]. - The total assets of the company reached RMB 3 billion by the end of 2021, reflecting a 10% increase from the previous year[29]. - The company achieved a revenue of 1.195 billion yuan in 2021, representing a year-on-year growth of 30%[88]. - The net profit attributable to shareholders reached 311 million yuan, with a year-on-year increase of 54%[88]. - Operating cash flow net amount was 350 million yuan, up 35% compared to the previous year[91]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 15% market share by 2025[29]. - The company is focusing on international market expansion while being aware of potential regulatory and geopolitical risks that could impact overseas operations[16]. - The company is actively expanding its international presence and market share, leveraging its first-mover advantage in the industry[49]. - The company is actively pursuing international market development, particularly in wet metallurgy and environmental protection sectors[191]. - The company aims to capture significant market opportunities in the lithium extraction sector, particularly in salt lake lithium extraction, and plans to enhance its market position through specialized project teams[188]. Research and Development - The company emphasizes the importance of continuous R&D investment to maintain competitive advantages and meet diverse customer needs in emerging application fields[10]. - The company has allocated RMB 200 million for R&D in 2022, focusing on advanced polymer materials[29]. - The company achieved a research and development investment of 6.43% of its operating revenue during the reporting period[78]. - The company has established a research and development team of over 200 members, covering various fields such as polymer materials and organic synthesis[76]. - The company has been recognized for its "VOCs efficient treatment resin adsorption technology" as part of the national ecological environment technology achievement transformation platform[79]. - The company is committed to developing new technologies and applications, although some new business areas are still in the early stages and have limited immediate revenue impact[18]. Product Development and Innovation - New product development includes a line of eco-friendly ion exchange resins, expected to launch in Q3 2022[29]. - The company has developed key technologies for the separation and recovery of lithium and nickel from solutions, contributing to resource utilization[79]. - The company has developed a high-efficiency nickel adsorbent that achieved the best performance indicators in East Asia nickel ore testing, contributing to its competitive edge in metal extraction[101]. - The company has expanded its product line in the life sciences sector, enhancing its influence and revenue potential through new technology and product development[154]. - The company has developed a second-generation protein A affinity material with a loading capacity exceeding 70 mg/ml, which is currently undergoing documentation for commercialization[155]. Operational Efficiency and Management - The company acknowledges risks related to management complexity due to rapid business growth and plans to enhance internal controls and management efficiency[8]. - The company is enhancing its human resources strategy to retain core technical personnel and prevent knowledge leakage, which is critical for maintaining its competitive edge[14]. - The company is focusing on dual-carbon strategies and ESG principles, integrating its technology with national carbon neutrality goals[195]. - The company plans to enhance its management systems to adapt to rapid growth and ensure operational efficiency[194]. - The company has adopted a refined management approach, utilizing data analysis to improve operational quality across various business segments[118]. Competition and Market Challenges - The company is facing increased competition in the adsorption separation materials market and aims to continuously innovate and improve product performance to maintain market share[9]. - The company faces intensified market competition due to increased investments from domestic and international manufacturers in emerging application fields[199]. - The company aims to maintain stable pricing and improve cost control in response to increased tariffs affecting overseas business profitability[143]. Financial Management and Investments - The company has maintained a debt-to-asset ratio of 32% as of the end of the reporting period[88]. - The total investment amount for the reporting period reached ¥179,684,059.91, representing a significant increase of 207.26% compared to ¥58,478,988.30 in the previous year[169]. - The company has confirmed that there are no idle funds remaining from the raised capital after the completion of the projects[181]. - The company has temporarily used idle raised funds to supplement working capital, with a balance of CNY 0 as of December 31, 2021[181]. Environmental and Regulatory Compliance - The company has obtained a health safety product license for drinking water-related products, valid until May 17, 2022[73]. - The company has an environmental management system certification valid until January 8, 2024, for its adsorption and ion exchange resin products[73]. - The company is focusing on technological innovation and expanding its application of adsorption separation technology in various fields, including lithium extraction from salt lake brine[137].